在药效学方面,应用GP-303血流动力学测定仪,我们选择了每搏量(SV)、平均动脉压(MAP)、心率(HR)和体循环阻力(TPR)作为药效学指标。
According to pharmacodynamics, the GP 303 instrument was used to detect the pharmacodynamics indexes such as SV, MAP, HR, and TPR.
在注入NOS抑制剂后总肺循环阻力、肺动脉阻力、体循环血管阻力均明显上升(P< 0 .0 5 )。
Total pulmonary resistance(TPR), pulmonary vascular resistance(PVR)and systemic vascular resistance(SVR) were increased after injected NOS inhibitor(P<0.05).
在注入NOS抑制剂后总肺循环阻力、肺动脉阻力、体循环血管阻力均明显上升(P< 0 .0 5 )。
Total pulmonary resistance(TPR), pulmonary vascular resistance(PVR)and systemic vascular resistance(SVR) were increased after injected NOS inhibitor(P<0.05).
应用推荐